Xiaohui Wang1, Long Ji1, Zhaoyang Tang1, Guoyong Ding1, Xueyu Chen1, Jian Lv1, Yanru Chen1, Dong Li2,3. 1. Department of Epidemiology, School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 619 Changcheng Road, Taian, 271016, P.R. China. 2. Department of Epidemiology, School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, 619 Changcheng Road, Taian, 271016, P.R. China. tsmcdongli@163.com. 3. The Second Affiliated Hospital of Shandong First Medical University, 706 Taisan Street, Taian, 271000, China. tsmcdongli@163.com.
Abstract
BACKGROUND: Metabolic syndrome (Mets) is prevalent in the general population and has been reported to be an independent risk factor for cognitive impairment. This study aimed to investigate the association of Mets with the risk of cognitive impairment. METHODS: We studied 5854 participants from the Jidong community. Cognitive function was assessed by the Mini-Mental State of Examination (MMSE) scale. Mets was diagnosed according to the International Diabetes Federation criteria. We used logistic regression analysis to investigate the association of metabolic syndrome with the risk of cognitive impairment. RESULT: Among the 5854 adults included in the study, the age mean (SD) of age was 44 (13.57) years, and 2916 (50.34%) were male. There was a higher (56.03%) cognitive impairment incidence rate among participants with Mets than among those without Mets. In addition, there was a significant association between Mets and cognitive impairment (OR: 2.39, 95% CI: 2.00-2.86, P < 0.05) after adjusting for potential confounders, including age, gender, education level, marital status, smoking and alcohol consumption status. Regarding the 5 Mets components, abdominal obesity and elevated blood pressure were associated with the risk of Mets (OR: 1.36, 95% CI: 1.09-1.70, P < 0.001; OR: 1.32, 95% CI: 1.07-1.63, P < 0.05). Moreover, the strongest statistical correlation (adjusted OR: 1.86, 95% CI: 1.22-2.83, P < 0.05) was found when the number of Mets components was three. CONCLUSION: Our study suggested that Mets was associated with cognitive impairment and that abdominal obesity and hypertension were associated with an increased risk of cognitive impairment.
BACKGROUND:Metabolic syndrome (Mets) is prevalent in the general population and has been reported to be an independent risk factor for cognitive impairment. This study aimed to investigate the association of Mets with the risk of cognitive impairment. METHODS: We studied 5854 participants from the Jidong community. Cognitive function was assessed by the Mini-Mental State of Examination (MMSE) scale. Mets was diagnosed according to the International Diabetes Federation criteria. We used logistic regression analysis to investigate the association of metabolic syndrome with the risk of cognitive impairment. RESULT: Among the 5854 adults included in the study, the age mean (SD) of age was 44 (13.57) years, and 2916 (50.34%) were male. There was a higher (56.03%) cognitive impairment incidence rate among participants with Mets than among those without Mets. In addition, there was a significant association between Mets and cognitive impairment (OR: 2.39, 95% CI: 2.00-2.86, P < 0.05) after adjusting for potential confounders, including age, gender, education level, marital status, smoking and alcohol consumption status. Regarding the 5 Mets components, abdominal obesity and elevated blood pressure were associated with the risk of Mets (OR: 1.36, 95% CI: 1.09-1.70, P < 0.001; OR: 1.32, 95% CI: 1.07-1.63, P < 0.05). Moreover, the strongest statistical correlation (adjusted OR: 1.86, 95% CI: 1.22-2.83, P < 0.05) was found when the number of Mets components was three. CONCLUSION: Our study suggested that Mets was associated with cognitive impairment and that abdominal obesity and hypertension were associated with an increased risk of cognitive impairment.
Authors: J Patrick O'Grady; Douglas C Dean; Kao Lee Yang; Cristybelle-Marie Canda; Siobhan M Hoscheidt; Erika J Starks; Andrew Merluzzi; Samuel Hurley; Nancy J Davenport; Ozioma C Okonkwo; Rozalyn M Anderson; Sanjay Asthana; Sterling C Johnson; Andrew L Alexander; Barbara B Bendlin Journal: Obesity (Silver Spring) Date: 2019-07-17 Impact factor: 5.002
Authors: F Panza; A D'Introno; A M Colacicco; A M Basile; C Capurso; P G Kehoe; A Capurso; V Solfrizzi Journal: J Neural Transm (Vienna) Date: 2003-12-03 Impact factor: 3.575
Authors: Mohammad Ziaul Islam Chowdhury; Ataul Mustufa Anik; Zaki Farhana; Piali Dey Bristi; B M Abu Al Mamun; Mohammad Jasim Uddin; Jain Fatema; Tanjila Akter; Tania Akhter Tani; Meshbahur Rahman; Tanvir C Turin Journal: BMC Public Health Date: 2018-03-02 Impact factor: 3.295
Authors: Jigar Gosalia; Polly S Montgomery; Shangming Zhang; William A Pomilla; Ming Wang; Menglu Liang; Anna Csiszar; Zoltan Ungvari; Andriy Yabluchanskiy; David N Proctor; Andrew W Gardner Journal: Geroscience Date: 2022-08-18 Impact factor: 7.581